MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.020
-0.020
-0.98%
After Hours: 2.020 0 0.00% 17:46 12/06 EST
OPEN
2.060
PREV CLOSE
2.040
HIGH
2.150
LOW
2.010
VOLUME
132.54K
TURNOVER
--
52 WEEK HIGH
24.45
52 WEEK LOW
1.780
MARKET CAP
7.62M
P/E (TTM)
-0.1058
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PSTV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PSTV News

  • Plus Therapeutics to Present at the LD Micro Main Event (XII)
  • GlobeNewswire.11/25 12:00
  • The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
  • Benzinga.11/21 12:22
  • Stocks That Hit 52-Week Lows On Wednesday
  • Benzinga.11/20 15:37
  • The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
  • Benzinga.11/20 12:25

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About PSTV

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
More

Webull offers Plus Therapeutics Inc (PSTV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.